The present invention relates to a method for producing encapsulated liquid oxygen to maintain blood homeostasis is disclosed. The composition contains a carrier, encapsulated nano-bubbles with one or more gases, preferably liquid oxygen. The methods and compositions may be administered to a patient to deliver liqui...

The present invention relates to nanoemulsion formulations and in particular nanoemulsion formulations for parenteral and non-parenteral delivery of liquid oxygen to a subject. The liquid oxygen nanoemulsion formulations of the present invention may be employed to increase blood oxygen saturation levels or to permit...

Title: “ANTIVIRAL FORMULATIONS FOR PULMONARY DRUG DELIIVERY” 7. ABSTRACT The invention relates to the combination of compounds for pulmonary infections conditions. The substances used in the combination according to the invention are a Lopinavir and Ritonavir. Their combined use provides a synergetic effect im...

Title: “COMBINATION OF HYDROXYCHLOROQUINE AND AZITHROMYCIN FOR PULMONARY DRUG DELIIVERY” 7. ABSTRACT The invention relates to the combination of two known active compounds for pulmonary infections purposes. The substances used in the combination according to the invention are a known active compound Azithromycin...

7. ABSTRACT The present invention discloses a novel stable, single-phase aqueous suspension for nasal administration designed to treat bacterial sinusitis. The composition comprises azithromycin dihydrate as the active ingredient and utilizes a suspending agent system to prevent phase separation during storage. Em...

7. ABSTRACT This invention provides a novel nebulization suspension comprising amoxicillin and clavulanate for the effective treatment of pneumonia. The formulation is specifically designed for pulmonary delivery, offering several advantages over traditional oral antibiotics. Key features include mucoadhesive prope...

7. ABSTRACT This invention describes a novel, stable, fixed-dose, aqueous suspension of Amoxicillin Clavulanate for nasal administration to treat post-surgical nasal infections. The formulation leverages a unique combination of excipients, including mucoadhesive agents like chitosan, to enhance drug delivery and ef...